Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
Ranke
M B
MB
Paediatric Endocrinology Section, University Children's Hospital, Tübingen, Germany.
Wollmann
H A
HA
Savage
M O
MO
D000273:Adipose Tissue / Q000187:drug effects; D001827:Body Height / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D019465:Craniofacial Abnormalities / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D004351:Drug Resistance / Q000235:genetics; D006130:Growth Disorders / Q000097:blood / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D019382:Human Growth Hormone / Q000172:deficiency / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000009:adverse effects / Q000032:analysis / Q000494:pharmacology* / Q000627:therapeutic use*; D013577:Syndrome
D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I